Depression Clinical Trials in Atlanta
View 66 new treatments for depression near you in Atlanta, GA. Every day, Power helps over 527 depression patients connect with leading medical research.NMRA-335140 for Depression
Neumora Clinic, Sandy Springs + 3 more
This trial is testing a new medication called NMRA-335140 to see if it can help people with severe depression. The study involves participants with Major Depressive Disorder and aims to find out if the medication can improve their mood by altering brain chemicals.Show More
Verified
ALTO-300 for Depression
Alto Neuroscience Clinic, Snellville + 3 more
This trial is testing ALTO-300, a new medication, to see if it can make antidepressants work better for patients who are already taking them.
Verified
Baricitinib for Depression in People With HIV
Research Clinic, Atlanta + 3 more
This trial tests whether the anti-inflammatory drug baricitinib can help people with HIV and depression by reducing inflammation. The study focuses on patients who have high inflammation and are already on effective HIV treatment. Researchers want to see if lowering inflammation can improve brain functions related to pleasure and movement, potentially easing depressive symptoms.Show More
Verified
AXS-05 for Depression
Axsome Clinic, Atlanta + 1 more
This trial is testing AXS-05, a new medication, to see if it can prevent depression from returning in people who have already improved with it. The study focuses on those with major depressive disorder and aims to maintain their balanced brain chemicals to keep them feeling better. AXS-05 (a combination of dextromethorphan and bupropion) has shown positive results in previous trials for major depressive disorder.Show More
No Placebo Trial
Dopaminergic Therapy for Depression with Anhedonia
Research Clinic, Atlanta + 1 more
The purpose of this 8-week, double-blind, placebo-controlled, study is to explore new treatment options for people with depression who have high inflammation and anhedonia. Seventy male and female participants with depression, between 25-55 years of age, with higher levels of inflammation and anhedonia will be randomized to receive L-DOPA or matched placebo over 8 weeks. Participants will complete lab tests, medical and psychiatric assessments, motivation and motor tasks, and MRI scans as part of the study. The total length of participation is approximately 10 to 12 weeks.Show More
Dopaminergic Therapy for Depression with Anhedonia
Research Clinic, Atlanta + 1 more
This trial tests L-DOPA, a medication that boosts dopamine, in people with depression who have high inflammation and can't feel pleasure. The goal is to see if increasing dopamine can improve their mood and ability to feel pleasure. L-DOPA is used to treat motor symptoms in Parkinson's disease by increasing dopamine levels in the brain.Show More
REL-1017 for Depression
Relmada Clinic, Grayson + 1 more
This trial tests if adding REL-1017 to current antidepressant treatments can better help people with Major Depressive Disorder. Participants will take their usual antidepressants plus either REL-1017 or another substance. The goal is to see if REL-1017 can improve their depression symptoms. REL-1017 (esmethadone) has shown potential rapid and sustained antidepressant effects in previous trials.Show More
Seltorexant for Depression
Janssen Clinic, Atlanta + 2 more
This trial is testing seltorexant to see if it can help people with depression and insomnia who haven't improved with their current antidepressants. Seltorexant aims to improve mood and sleep by acting on certain brain receptors.Show More
Psilocybin for Depression
Research Clinic, Atlanta + 2 more
This trial is testing psilocybin, a substance from mushrooms, to see if it can help adults with depression who may not respond well to current treatments. Psilocybin works by affecting brain chemicals related to mood. Psilocybin has shown promise as a treatment for major depressive disorder and was designated as a breakthrough therapy by the FDA in 2019.Show More
Cariprazine for Bipolar Disorder in Youth
AbbVie Clinic, Stockbridge + 5 more
This trial is testing the safety and effectiveness of Cariprazine for treating depressive episodes in children and teenagers with bipolar I disorder. The goal is to find out if Cariprazine can help young people with this condition. Cariprazine is an atypical antipsychotic recently approved for the treatment of depressive episodes in adults with bipolar I disorder.Show More
Frequently Asked Questions
How much do depression clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range. Further, most trials will cover the costs of an Uber to-and-from the clinic. Factors that can affect compensation include the phase of the trial, the length of the trial, the frequency of visits, and the specific condition being studied.
Do I need to be insured to participate in a medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on Cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
How do depression clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll typical be sorted into one of the treatment groups, and will receive your study drug. For some trials, there is a chance you'll receive a placebo. Across depression trials in New York City, 42% of clinical trials have a placebo. Typically you'll be required to check-in with the clinic every month or two. The average trial length in this city for depression patients is 6 Months.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in getting approval for a specific condition. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. Phase 2 trials are those where the drug has some data showing safety in humans, but where effectiveness has typically only been shown in animals and non-human experiments. Phase 1 trials are the trials where we don't have safety data in humans. As a general rule, phase 3 trials are more promising than phase 2, and phase 2 trials are more promising than phase 1.
How many people will have already taken the drug in my study?
This depends on the phase of the trial, as well as the condition. For drugs that are in Phase 3, it's typical that at least 200 many patients will have participated over the first and second phases. For Phase 2, 100 is the typical number of people who will have participated.
Where in New York City is research being conducted?
Manhattan is the most active borough in New York City for clinical trials in depression, with neighborhoods such as the Upper East Side and Midtown hosting major research centers. The top individual hospitals include Memorial Sloan Kettering Cancer Center, Columbia University Medical Center, Icahn School of Medicine at Mount Sinai, and NYU Langone Health, which collectively run the majority of depression clinical trials in the city.
What promising new drugs are being tested?
Many of the drugs being researched near New York City work via glutamate: the main excitatory signal in the brain. Some of these drugs shift how your natural glutamate functions and others, like ketamine, block one of the receptors that glutamate works on. The other common category of drugs being explored are psychedelics, like psilocybin, which are thought to work by helping your brain become more plastic. Other drugs being researched in multiple trials include Aticaprant and BHV-7000.
What non-medication treatments are being researched?
Non-drug treatments for depression being researched in clinical trials in New York City can be categorized into psychotherapy, digital and mobile app-based interventions, brain stimulation techniques like TMS, and educational and training programs. These trials include approaches like Cognitive Behavioral Therapy, mindfulness, family support, symptom education, and neurofeedback.
Why are others applying to these studies?
I have tried two other drugs that didn't have any positive affect on my mental health and am hoping that trying out this trial will help me find a solution.
M.A. Patient
Depression Patient
I've tried many anti-depressants in my 45 year struggle with Major Depression. I'm hoping this study is the 'game changer'
B.E. Patient
Late-Life Depression Patient
I've tried more then 5 drugs for depression and it's very depressing frustrating when they do not work, or even help nothing, I'm still looking for that one or 2 that will help
A.L. Patient
Major Depression Patient